Clinical Trial Update: Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial [Phase 2, Phase 3]

View source ↗

Summary

Trial update for intraperitoneal therapy with carboplatin in epithelial ovarian cancer and related conditions; the study has completed phases 2 and 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Gynecologic Oncology Trial & Investigation Consortium | Conditions: Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 2, Phase 3 | Status: COMPLETED